The issue of renal safety of zoledronic acid from a nephrologist's point of view [2] (multiple letters)

Oncologist

Volumn 10, Issue 5, 2005, Pages 306-319

  Balla, József ^a   Lugassy, Gilles ^b   Berenson, James ^c   Jackson, Graham ^d   Conte, PierFranco ^e   Guarneri, Valentina ^e   Body, Jean Jacques ^f  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b BARZILAI MEDICAL CENTER   (Israel)

^c INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH   (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ZOLEDRONIC ACID;

ACUTE KIDNEY TUBULE NECROSIS; BONE CANCER; BONE METASTASIS; CHRONIC KIDNEY DISEASE; DRUG SAFETY; GLOMERULOSCLEROSIS; HUMAN; KIDNEY FUNCTION; LETTER; NEPHROTOXICITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 18444413286     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.10-5-306     Document Type: Letter

References (0)